About Medion BioTech
Medion BioTech is an Industrial Goods & Manufacturing company founded in 2012. Manufacturing and supplying formulations in oncology for Indian and international markets. It operates in the Industrial Goods & Manufacturing and Healthcare sectors. The company has 29 employees. Its Indian entity Medion Biotech Private Limited reported revenue of ₹29.50 Cr. Medion BioTech offers products and services including Oncology Formulations and Contract Manufacturing Services. Its focus areas include Manufacturing, Contract Manufacturing, International Supply and Pharmaceuticals.
Company details
Medion BioTech is identified as a leading manufacturer and supplier of high-quality formulations in oncology, with operations established since 2012. Global quality standards are adhered to by the company to serve both domestic and international markets, focusing on niche therapy areas. Advanced manufacturing capabilities equipped with sophisticated tools are utilized to deliver healthcare solutions, ensuring products meet required specifications without deviation from established protocols.
- Employees 29
- SectorsIndustrial Goods & ManufacturingHealthcare
- Email••••••••
- Phone•••• ••••
- Website medionbiotech.com
- Legal Name Medion Biotech Pvt. Ltd
- Date of Incorporation 09 Apr, 2012
- Jurisdiction Delhi, India
- Indian entity revenue₹29.50 Cr
FY 2025 · +1% YoY
- Indian entity net profit₹76.6 Lakh
FY 2025 · 3% margin
- Indian entity EBITDA₹2.73 Cr
FY 2025 · 9% margin
- Employee Count29
Associated legal entities of Medion BioTech
Medion BioTech operates through Medion Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medion Biotech Private Limited CIN U51909DL2012PTC234100 | Active | 09 Apr 2012 | Delhi, Delhi | ₹29.5 Cr | 29 | 4 | View details |
Products & Services of Medion BioTech
Medion BioTech offers a comprehensive portfolio of products and services, including Oncology Formulations and Contract Manufacturing Services.
Formulations for oncology treatments are manufactured and supplied by the company in niche therapy areas.
Contract manufacturing services are provided by the company for pharmaceutical products in various markets.
Board of directors of Medion Biotech Private Limited (Medion BioTech)
Medion Biotech Private Limited is the primary company behind Medion BioTech. The board of Medion Biotech Private Limited currently have 4 directors; the longest-serving is Rinku Kumari, appointed in 2014. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rinku Kumari DIN 07043199 | Director | 04 Dec 2014 | 11 yrs 11 mo | Medion Biotech Private Limited |
| Kapil Dev DIN 05229285 | Director | 04 Dec 2014 | 11 yrs 11 mo | Medion Biotech Private Limited |
| Prateek Sachdeva DIN 09567575 | Director | 11 Apr 2022 | 4 yrs 6 mo | Medion Biotech Private Limited |
| Ram Bujhawan DIN 05229287 | Director | 15 Nov 2025 | 11 mo | Medion Biotech Private Limited |
Financials of Medion BioTech
Figures of Medion Biotech Private Limited, the primary company behind Medion BioTech, for FY 2025. Revenue was ₹29.50 Cr (+1% year on year). Net profit was ₹76.6 Lakh (3% margin). EBITDA was ₹2.73 Cr (9% margin). Revenue has grown at a compounded annual rate of +65% over three years and +46% over five years.
- ₹29.50 CrRevenue · FY 2025 · +1% YoY
- ₹76.6 LakhNet profit · 3% margin
- ₹2.73 CrEBITDA · 9% margin
- ₹50 LakhPaid-up capital
- 29Employees (provident fund records)
- +65%Revenue CAGR, 3 years
- +46%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medion Biotech Private Limited are on its company page.
Detailed financial statements for Medion BioTech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medion BioTech
Medion BioTech was founded in 2012.
Medion BioTech has 29 employees.
The primary company behind Medion BioTech, Medion Biotech Private Limited, reported revenue of ₹29.50 Cr for FY 2025, up 1% year on year.
Medion BioTech is identified as a leading manufacturer and supplier of high-quality formulations in oncology, with operations established since 2012. Global quality standards are adhered to by the company to serve both domestic and international markets, focusing on niche therapy areas. Advanced manufacturing capabilities equipped with sophisticated tools are utilized to deliver healthcare solutions, ensuring products meet required specifications without deviation from established protocols.
Medion BioTech offers Oncology Formulations and Contract Manufacturing Services.
Medion BioTech operates through Medion Biotech Private Limited.
The legal entities of Medion BioTech currently have 4 directors, including Rinku Kumari, Ram Bujhawan, Kapil Dev and others.